Your browser doesn't support javascript.
loading
A robust machine learning framework to identify signatures for frailty: a nested case-control study in four aging European cohorts.
Gomez-Cabrero, David; Walter, Stefan; Abugessaisa, Imad; Miñambres-Herraiz, Rebeca; Palomares, Lucia Bernad; Butcher, Lee; Erusalimsky, Jorge D; Garcia-Garcia, Francisco Jose; Carnicero, José; Hardman, Timothy C; Mischak, Harald; Zürbig, Petra; Hackl, Matthias; Grillari, Johannes; Fiorillo, Edoardo; Cucca, Francesco; Cesari, Matteo; Carrie, Isabelle; Colpo, Marco; Bandinelli, Stefania; Feart, Catherine; Peres, Karine; Dartigues, Jean-François; Helmer, Catherine; Viña, José; Olaso, Gloria; García-Palmero, Irene; Martínez, Jorge García; Jansen-Dürr, Pidder; Grune, Tilman; Weber, Daniela; Lippi, Giuseppe; Bonaguri, Chiara; Sinclair, Alan J; Tegner, Jesper; Rodriguez-Mañas, Leocadio.
Afiliação
  • Gomez-Cabrero D; Translational Bioinformatics Unit, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), IdiSNA, Pamplona, Spain.
  • Walter S; Dept. of Medicine and Public Health, Rey Juan Carlos University, Alcorcon, Spain.
  • Abugessaisa I; Dept. of Medicine, Karolinska Institute, Stockholm, Sweden.
  • Miñambres-Herraiz R; Sistemas Genomicos, Valencia, Spain.
  • Palomares LB; Sistemas Genomicos, Valencia, Spain.
  • Butcher L; Department of Biomedical Sciences, Cardiff Metropolitan University, Cardiff, UK.
  • Erusalimsky JD; Department of Biomedical Sciences, Cardiff Metropolitan University, Cardiff, UK.
  • Garcia-Garcia FJ; Dept. of Geriatric Medicine, Complejo Hospitalario Universitario de Toledo (CHUT), Toledo, Spain.
  • Carnicero J; Dept. of Geriatric Medicine, Complejo Hospitalario Universitario de Toledo (CHUT), Toledo, Spain.
  • Hardman TC; Niche Science & Technology Ltd., Richmond-upon-Thames, London, UK.
  • Mischak H; Mosaiques Diagnostics GmbH, Rotenburger Str. 20, 30659, Hannover, Germany.
  • Zürbig P; Mosaiques Diagnostics GmbH, Rotenburger Str. 20, 30659, Hannover, Germany.
  • Hackl M; Evercyte GmbH; BOKU-University of Natural Resources and Life Sciences Vienna, Department of Biotechnology, Ludwig Boltzmann Institute of Experimental and Clinical Traumatology, Vienna, Austria.
  • Grillari J; Evercyte GmbH; BOKU-University of Natural Resources and Life Sciences Vienna, Department of Biotechnology, Ludwig Boltzmann Institute of Experimental and Clinical Traumatology, Vienna, Austria.
  • Fiorillo E; Instituto di Ricerca Genetica e Biomedica, Consiglio Nazionale delle Ricerche, Monserrato, Cagliari, Italy.
  • Cucca F; Instituto di Ricerca Genetica e Biomedica, Consiglio Nazionale delle Ricerche, Monserrato, Cagliari, Italy.
  • Cesari M; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.
  • Carrie I; Gérontopôle, Toulouse, France.
  • Colpo M; USL Centro Toscana, Firenze, Italy.
  • Bandinelli S; USL Centro Toscana, Firenze, Italy.
  • Feart C; Univ. Bordeaux, Bordeaux Population Health Research Center, UMR 1219, F-33000, Bordeaux, France.
  • Peres K; Univ. Bordeaux, Bordeaux Population Health Research Center, UMR 1219, F-33000, Bordeaux, France.
  • Dartigues JF; Univ. Bordeaux, Bordeaux Population Health Research Center, UMR 1219, F-33000, Bordeaux, France.
  • Helmer C; Univ. Bordeaux, Bordeaux Population Health Research Center, UMR 1219, F-33000, Bordeaux, France.
  • Viña J; Freshage, University of Valencia, Valencia, Spain.
  • Olaso G; Freshage, University of Valencia, Valencia, Spain.
  • García-Palmero I; Lifelength, Madrid, Spain.
  • Martínez JG; Lifelength, Madrid, Spain.
  • Jansen-Dürr P; Research Institute for Biomedical Aging Research, University of Innsbruck, Innsbruck, Austria.
  • Grune T; German Institute for Human Nutrition, Potsdam, Germany.
  • Weber D; German Institute for Human Nutrition, Potsdam, Germany.
  • Lippi G; Clinical Biochemistry and Molecular Biology, Universita di Verona, Verona, Italy.
  • Bonaguri C; Laboratoy Medicine Technical Sciences, Parma University, Parma, Italy.
  • Sinclair AJ; Diabetes Frail and King's College, London, Se1 8WA, UK.
  • Tegner J; Dept. of Medicine, Karolinska Institute, Stockholm, Sweden.
  • Rodriguez-Mañas L; Biological and Environmental Science and Engineering Division, King Abdullah University of Science and Technology, Thuwal, Saudi Arabia.
Geroscience ; 43(3): 1317-1329, 2021 06.
Article em En | MEDLINE | ID: mdl-33599920
ABSTRACT
Phenotype-specific omic expression patterns in people with frailty could provide invaluable insight into the underlying multi-systemic pathological processes and targets for intervention. Classical approaches to frailty have not considered the potential for different frailty phenotypes. We characterized associations between frailty (with/without disability) and sets of omic factors (genomic, proteomic, and metabolomic) plus markers measured in routine geriatric care. This study was a prevalent case control using stored biospecimens (urine, whole blood, cells, plasma, and serum) from 1522 individuals (identified as robust (R), pre-frail (P), or frail (F)] from the Toledo Study of Healthy Aging (R=178/P=184/F=109), 3 City Bordeaux (111/269/100), Aging Multidisciplinary Investigation (157/79/54) and InCHIANTI (106/98/77) cohorts. The analysis included over 35,000 omic and routine laboratory variables from robust and frail or pre-frail (with/without disability) individuals using a machine learning framework. We identified three protective biomarkers, vitamin D3 (OR 0.81 [95% CI 0.68-0.98]), lutein zeaxanthin (OR 0.82 [95% CI 0.70-0.97]), and miRNA125b-5p (OR 0.73, [95% CI 0.56-0.97]) and one risk biomarker, cardiac troponin T (OR 1.25 [95% CI 1.23-1.27]). Excluding individuals with a disability, one protective biomarker was identified, miR125b-5p (OR 0.85, [95% CI 0.81-0.88]). Three risks of frailty biomarkers were detected pro-BNP (OR 1.47 [95% CI 1.27-1.7]), cardiac troponin T (OR 1.29 [95% CI 1.21-1.38]), and sRAGE (OR 1.26 [95% CI 1.01-1.57]). Three key frailty biomarkers demonstrated a statistical association with frailty (oxidative stress, vitamin D, and cardiovascular system) with relationship patterns differing depending on the presence or absence of a disability.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fragilidade Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans Idioma: En Revista: Geroscience Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fragilidade Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans Idioma: En Revista: Geroscience Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha